Skip navigation

  1. Try the new Globe Investor beta site

    We're building you a new Globe Investor that is smarter, faster and easier to use.
    We'll be rolling out new sections, features and tools over the coming months.

GlobeinvestorGOLD Canada's most comprehensive investment tool.

Change Symbol: lookup Trade Now

Covidien | COV-N

  • US$ 45.650
  • +0.520
  • +1.15%
  • 16:00:44 EST Nov 20, 2009
Open Mkt Cap ($Mil)
23,008
High EPS (ttm)
Low P/E (ttm)
Bid Forward P/E 12.61
Ask PEG (est. 5 yrs) 1.35
Volume Annual Div.
52-wk High 11/17 46.750 Yield
52-wk Low 03/09 27.270 5-star Rating Stars

Quotes delayed 15 minutes.

Intraday Stock Activity Measures

Recent News

Covidien(COV-N)
Intraday chart
     

Intraday 1 Mo 3 Mo 6 Mo 1 Yr 3 Yr 5 Yr

Interactive Charts

Annual Financials

hide
  3-Yr. Growth %

Sep 2008
12 Mo us$
Sep 2007
12 Mo us$
Sep 2006
12 Mo us$
Total Revenue ($Mil) - 9,910 10,170 9,647
Sales/Share - 19.82 20.46 19.41
Profit ($Mil) - 1,361 -342 1,155
EPS - 2.72 -0.69 2.33
Cash Flow/Share - 2.89 -0.68 -
Book Value/Share - 15.44 13.56 -
Ret on Common Equity - 18.79 - -
Debt to Equity - 0.39 0.61 -
 
Earnings Per Share Trend (US$) Sales Per Share Trend (US$)
EPS_Chart Chart

View Company Snapshot    View Full Financials   

Competitors

hide

Key Competitors based on Market Cap in Consumer Products Industry

           

Earnings Estimates

hide
Analyst Estimates

Currency: US$

  Current Qtr Next Qtr Fiscal Yr Fiscal Yr
  Dec 2009 Mar 2010 Sep 2010 Sep 2011
Mean Estimated EPS 0.75 0.81 3.27 3.62
Year Ago EPS 0.76 0.69 2.84 3.27
Growth Rate (vs. Year Ago) -1.32% 17.39% 15.14% 10.70%
Number of Brokers 17 15 17 14
Current High Estimate 0.81 0.88 3.36 3.70
Current Low Estimate 0.60 0.77 3.20 3.50
Current Median EPS 0.76 0.80 3.27 3.63

Consensus Recommendation: Strong Buy (13 brokers)

Estimated EPS vs. Actual EPS

Chart

View Full Estimates Snapshots

Back to top